(Q44519261)

3 December 2017

title

Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection (English)

1 reference

3 December 2017

Cytotoxic-T-Cell Responses, Viral Load, and Disease Progression in Early Human Immunodeficiency Virus Type 1 Infection (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

21 November 2024

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9345075

21 November 2024

6

McElrath MJ

1 reference

3 December 2017

6

M. J. McElrath

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9345075

21 November 2024

author name string

L. Musey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9345075

21 November 2024

J. Hughes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9345075

21 November 2024

T. Schacker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9345075

21 November 2024

T. Shea

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9345075

21 November 2024

L. Corey

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9345075

21 November 2024

language of work or name

English

0 references

publication date

1 October 1997

1 reference

3 December 2017

30 October 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9345075

full work available at URL

21 November 2024

http://www.nejm.org/doi/pdf/10.1056/NEJM199710303371803

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

The New England Journal of Medicine

21 November 2024

published in

1 reference

3 December 2017

volume

337

1 reference

3 December 2017

issue

18

1 reference

3 December 2017

page(s)

1267-1274

1 reference

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection

3 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 November 2024

2

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

21 November 2024

3

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

21 November 2024

4

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

21 November 2024

5

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

21 November 2024

6

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

21 November 2024

7

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS.

21 November 2024

8

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors

21 November 2024

9

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

21 November 2024

10

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease

21 November 2024

11

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

21 November 2024

12

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

21 November 2024

13

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

21 November 2024

16

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression

21 November 2024

17

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Reduction of HIV concentration during acute infection: independence from a specific immune response.

21 November 2024

18

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Population dynamics of immune responses to persistent viruses.

21 November 2024

19

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection

21 November 2024

20

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Clinical and epidemiologic features of primary HIV infection

21 November 2024

21

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma

21 November 2024

22

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial

21 November 2024

23

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus.

21 November 2024

24

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Cytotoxic T Lymphocyte Lines Specific for Human Immunodeficiency Virus Type 1 Gag and Reverse Transcriptase Derived from a Vertically Infected Child

21 November 2024

25

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses

21 November 2024

26

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

21 November 2024

27

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Clonal transformation of adult human leukocytes by Epstein-Barr virus

21 November 2024

28

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women

21 November 2024

29

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Enumeration of viral antigen-reactive helper T lymphocytes in human peripheral blood by limiting dilution for analysis of viral antigen-reactive T-cell pools in virus-seropositive and virus-seronegative individuals

21 November 2024

32

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities

21 November 2024

35

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection

21 November 2024

37

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Conserved V3 loop sequences and transmission of human immunodeficiency virus type 1.

21 November 2024

38

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses

21 November 2024

39

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor

21 November 2024

40

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

21 November 2024

41

1 reference

https://api.crossref.org/works/10.1056/NEJM199710303371803

21 November 2024

Identifiers

1 reference

3 December 2017

1 reference